EXTH-54. MULTIVALENT TARGETED PROTEINS FOR GLIOBLASTOMA TREATMENT

A heterogeneous and infiltrating tumor like glioblastoma (GBM) cannot be effectively treated with a single-targeted therapy. Hence, targeting several GBM-associated factors that are responsible for the disease progression and/or recurrence at once is a way to address the issue of tumor heterogeneity...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Sharma, Puja, Herpai, Denise, Rossmeisl, John, Tatter, Stephen, Debinski, Waldemar
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Experimental Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847866/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.385
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items